These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1932288)

  • 1. Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C.
    Lusher JM
    Ann Hematol; 1991 Sep; 63(3):138-41. PubMed ID: 1932288
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrapure plasma factor VIII produced by anti-F VIII c immunoaffinity chromatography and solvent/detergent viral inactivation. Characterization of the Method M process and Hemofil M antihemophilic factor (human).
    Griffith M
    Ann Hematol; 1991 Sep; 63(3):131-7. PubMed ID: 1932287
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihemophilic factor isolated with monoclonal antibodies.
    Gomperts ED
    Ann Hematol; 1991 Sep; 63(3):142-4. PubMed ID: 1932289
    [No Abstract]   [Full Text] [Related]  

  • 4. Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.
    Bergman GE
    Lancet; 1995 Nov; 346(8985):1296-7. PubMed ID: 7475737
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of highly purified factor VIII products.
    Beeser H
    Ann Hematol; 1991 Sep; 63(3):126-30. PubMed ID: 1657208
    [No Abstract]   [Full Text] [Related]  

  • 6. Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.
    Kessler C; Lusher J; Pierce GF; Pierce B; Koerper MA; Dickinson JC
    Lancet; 1995 Nov; 346(8985):1297-8. PubMed ID: 7475738
    [No Abstract]   [Full Text] [Related]  

  • 7. Preclinical characterization of a new pasteurized monoclonal antibody purified factor VIIIC.
    Hrinda ME; Feldman F; Schreiber AB
    Semin Hematol; 1990 Apr; 27(2 Suppl 2):19-24. PubMed ID: 2128854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate.
    Berntorp E; Nilsson IM; Ljung R; Widell A
    Lancet; 1990 Jun; 335(8704):1531-2. PubMed ID: 1972463
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro characteristics of highly purified factor VIII concentrates.
    Morfini M
    Ann Hematol; 1991 Sep; 63(3):123-5. PubMed ID: 1932286
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient inhibitor to monoclonal antibody-purified factor VIII concentrate.
    Votaw ML; Miller S
    Am J Hematol; 1992 Dec; 41(4):297. PubMed ID: 1288295
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV seroconversion in haemophilic boys receiving heat-treated factor VIII concentrate.
    Williams MD; Skidmore SJ; Hill FG
    Vox Sang; 1990; 58(2):135-6. PubMed ID: 2111060
    [No Abstract]   [Full Text] [Related]  

  • 12. Viral safety and inhibitor development associated with factor VIIIC ultra-purified from plasma in hemophiliacs previously unexposed to factor VIIIC concentrates. The Monoclate Study Group.
    Lusher JM; Salzman PM
    Semin Hematol; 1990 Apr; 27(2 Suppl 2):1-7. PubMed ID: 1965615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with Hemofil M in a hemophilia patient exhibiting inhibitors.
    Ingerslev J; Wallevik K
    Ann Hematol; 1991 Sep; 63(3):152-4. PubMed ID: 1932291
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemolytic anemia and F. VIII concentrate.
    Girelli G
    Eur J Haematol; 1989 Apr; 42(4):414. PubMed ID: 2498124
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor VIII solutions in pre-filled syringes.
    Peerlinck K; Arnout J; Vermylen J
    Lancet; 1992 Feb; 339(8788):303-4. PubMed ID: 1346301
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulation factor VIII concentrates and the marketplace.
    Lancet; 1988 Jul; 2(8601):42-3. PubMed ID: 2898643
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hemophilia A with a highly purified factor VIII concentrate prepared by anti-FVIIIc immunoaffinity chromatography.
    Addiego JE; Gomperts E; Liu SL; Bailey P; Courter SG; Lee ML; Neslund GG; Kingdon HS; Griffith MJ
    Thromb Haemost; 1992 Jan; 67(1):19-27. PubMed ID: 1615478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclate: a purified antihemophilic factor.
    Med Lett Drugs Ther; 1988 Jan; 30(756):1-2. PubMed ID: 3121992
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous infusion of monoclonal antibody-purified factor VIII.
    Weinstein RE; Bona RD; Rickles FR
    Am J Hematol; 1991 Mar; 36(3):211-2. PubMed ID: 1899966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient factor VIII inhibitor and treatment with monoclonal-antibody-purified factor VIII.
    Montoro JB; Rodríguez S; Altisent C; Tusell JM
    Lancet; 1991 May; 337(8751):1222. PubMed ID: 1673757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.